P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000970848.13342.8d |
_version_ | 1797279886843314176 |
---|---|
author | Zachary Zaroogian Elżbieta Adamczyk Adrianna Moszyńska Marta Obacz Urszula Pakulska Benjamin Durham Milena Mazan Shoron Mowla Katarzyna Wnęk Amritha Varshini Hanasoge Somasundara Beata Barczuk Aniela Gołas Ross Levine Tomasz Rzymski Raajit K Rampal |
author_facet | Zachary Zaroogian Elżbieta Adamczyk Adrianna Moszyńska Marta Obacz Urszula Pakulska Benjamin Durham Milena Mazan Shoron Mowla Katarzyna Wnęk Amritha Varshini Hanasoge Somasundara Beata Barczuk Aniela Gołas Ross Levine Tomasz Rzymski Raajit K Rampal |
author_sort | Zachary Zaroogian |
collection | DOAJ |
first_indexed | 2024-03-07T16:32:27Z |
format | Article |
id | doaj.art-512f19d4f82d4000871ea3e889e115ae |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:32:27Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-512f19d4f82d4000871ea3e889e115ae2024-03-03T10:07:35ZengWileyHemaSphere2572-92412023-08-017e133428d10.1097/01.HS9.0000970848.13342.8d202308003-00886P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMSZachary Zaroogian0Elżbieta Adamczyk1Adrianna Moszyńska2Marta Obacz3Urszula Pakulska4Benjamin Durham5Milena Mazan6Shoron Mowla7Katarzyna Wnęk8Amritha Varshini Hanasoge Somasundara9Beata Barczuk10Aniela Gołas11Ross Levine12Tomasz Rzymski13Raajit K Rampal141 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United States2 Ryvu Therapeutics, Kraków, Poland2 Ryvu Therapeutics, Kraków, Poland2 Ryvu Therapeutics, Kraków, Poland2 Ryvu Therapeutics, Kraków, Poland1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United States2 Ryvu Therapeutics, Kraków, Poland1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United States2 Ryvu Therapeutics, Kraków, Poland1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United States2 Ryvu Therapeutics, Kraków, Poland2 Ryvu Therapeutics, Kraków, Poland1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United States2 Ryvu Therapeutics, Kraków, Poland1 Memorial Sloan Kettering Cancer Center, Human Oncology and Pathogenesis Program, New York, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000970848.13342.8d |
spellingShingle | Zachary Zaroogian Elżbieta Adamczyk Adrianna Moszyńska Marta Obacz Urszula Pakulska Benjamin Durham Milena Mazan Shoron Mowla Katarzyna Wnęk Amritha Varshini Hanasoge Somasundara Beata Barczuk Aniela Gołas Ross Levine Tomasz Rzymski Raajit K Rampal P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS HemaSphere |
title | P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS |
title_full | P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS |
title_fullStr | P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS |
title_full_unstemmed | P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS |
title_short | P986: COMBINATION JAK1/2 AND CDK8/19 INHIBITION DEMONSTRATES ENHANCED EFFICACY IN MYELOPROLIFERATIVE NEOPLASMS |
title_sort | p986 combination jak1 2 and cdk8 19 inhibition demonstrates enhanced efficacy in myeloproliferative neoplasms |
url | http://journals.lww.com/10.1097/01.HS9.0000970848.13342.8d |
work_keys_str_mv | AT zacharyzaroogian p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT elzbietaadamczyk p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT adriannamoszynska p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT martaobacz p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT urszulapakulska p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT benjamindurham p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT milenamazan p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT shoronmowla p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT katarzynawnek p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT amrithavarshinihanasogesomasundara p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT beatabarczuk p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT anielagołas p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT rosslevine p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT tomaszrzymski p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms AT raajitkrampal p986combinationjak12andcdk819inhibitiondemonstratesenhancedefficacyinmyeloproliferativeneoplasms |